Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Immunosuppression in uveitis therapy.

× No keyword cloud information.

36 in total

1. High-dose short-term chlorambucil for intractable sympathetic ophthalmia and Behçet's disease.

Authors: H H Tessler; T Jennings
Journal: Br J Ophthalmol Date: 1990-06 Impact factor: 4.638

2. Neoral--new cyclosporin for old?

Authors: M F Somerville; D G Scott
Journal: Br J Rheumatol Date: 1997-10

3. The efficacy of cyclosporin-a in the treatment of Behçet's disease.

Authors: L S Atmaca; F Batioğlu
Journal: Ophthalmic Surg Date: 1994-05

4. Double-blind pilot trial of oral tolerization with myelin antigens in multiple sclerosis.

Authors: H L Weiner; G A Mackin; M Matsui; E J Orav; S J Khoury; D M Dawson; D A Hafler
Journal: Science Date: 1993-02-26 Impact factor: 47.728

5. Cyclosporine: a therapy in inflammatory eye disease.

Authors: D Wakefield; P McCluskey
Journal: J Ocul Pharmacol Date: 1991

6. Ocular toxicity of antineoplastic agents.

Authors: F T Fraunfelder; S M Meyer
Journal: Ophthalmology Date: 1983-01 Impact factor: 12.079

7. Treatment of severe refractory uveitis with intravenous cyclophosphamide.

Authors: J T Rosenbaum
Journal: J Rheumatol Date: 1994-01 Impact factor: 4.666

8. Triple agent immunosuppression in serpiginous choroiditis.

Authors: P L Hooper; H J Kaplan
Journal: Ophthalmology Date: 1991-06 Impact factor: 12.079

9. Synergistic effect of rapamycin and cyclosporin A in the treatment of experimental autoimmune uveoretinitis.

Authors: D F Martin; L R DeBarge; R B Nussenblatt; C C Chan; F G Roberge
Journal: J Immunol Date: 1995-01-15 Impact factor: 5.422

10. Long-term neoplasia risk after azathioprine treatment in inflammatory bowel disease.

Authors: W R Connell; M A Kamm; M Dickson; A M Balkwill; J K Ritchie; J E Lennard-Jones
Journal: Lancet Date: 1994-05-21 Impact factor: 79.321

1 in total

1. Anti-tumour necrosis factor biological therapies for the treatment of uveitic macular oedema (UMO) for non-infectious uveitis.

Authors: Robert J Barry; Mohammad O Tallouzi; Nick Bucknall; Jonathan M Mathers; Philip I Murray; Melanie J Calvert; David J Moore; Alastair K Denniston
Journal: Cochrane Database Syst Rev Date: 2018-12-18

1 in total